{"content":"<li class=\"n-box-item date-title\" data-end=\"1381204799\" data-start=\"1381118400\" data-txt=\"Friday, December 20, 2019\">Monday, October  7, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1317562\" data-ts=\"1381182310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317562-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After - Hour Gainers / Losers</a></h4><ul>     <li>\n<b>Top Gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/TLM\" title=\"Talisman Energy Inc.\">TLM</a> <font color=\"green\">+13.7%</font>. <a href=\"https://seekingalpha.com/symbol/ANV\" title=\"Allied Nevada Gold Corp\">ANV</a> <font color=\"green\">+3.5%</font>. <a href=\"https://seekingalpha.com/symbol/ZSL\" title=\"ProShares UltraShort Silver ETF\">ZSL</a> <font color=\"green\">+2.2%</font>. <a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a> <font color=\"green\">+2.1%</font>. NBG <font color=\"green\">+2.0%</font>.</li>\n<li>\n<b>Top Losers, </b><b><b>as of 5:15 p.m.</b>:</b> <a href=\"https://seekingalpha.com/symbol/TWGP\" title=\"Tower Group, Inc.\">TWGP</a> <font color=\"red\">-26.8%</font>. <a href=\"https://seekingalpha.com/symbol/NES\" title=\"Nuverra Environmental Solutions, Inc.\">NES</a> <font color=\"red\">-10.9%</font>. <a href=\"https://seekingalpha.com/symbol/JMBA\" title=\"Jamba, Inc.\">JMBA</a> <font color=\"red\">-8.6%</font>. NQ <font color=\"red\">-4.8%</font>. <a href=\"https://seekingalpha.com/symbol/MBT\" title=\"Mobile TeleSystems\">MBT</a> <font color=\"red\">-3.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317562\" data-linked=\"After - Hour Gainers / Losers\" data-tweet=\"$TLM $ANV $ZSL - After - Hour Gainers / Losers https://seekingalpha.com/news/1317562-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1317562-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317542\" data-ts=\"1381181704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLM\" target=\"_blank\">TLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317542-talisman-energy-plus-6_5-percent-ah-as-icahn-discloses-61m-share-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talisman Energy +6.5% AH as Icahn discloses 61M-share stake</a></h4><ul>     <li>Talisman Energy (NYSE:<a href='https://seekingalpha.com/symbol/TLM' title='Talisman Energy Inc.'>TLM</a>) <font color='green'>+6.5%</font> AH after surging 4.6% in the final minutes of regular trading, as Carl Icahn <a href=\"http://www.sec.gov/Archives/edgar/data/201283/000092846413000253/tlmsch13d100713.htm\" target=\"_blank\">discloses a 61M-share stake</a>, or 5.97%, in the company.</li><li>Icahn tweets that he \"<a href=\"https://twitter.com/Carl_C_Icahn/status/387324829432426496\" target=\"_blank\">may have conversations</a>\" with TLM's management regarding strategic alternatives and board seats.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1317542\" data-linked=\"Talisman Energy +6.5% AH as Icahn discloses 61M-share stake\" data-tweet=\"$TLM - Talisman Energy +6.5% AH as Icahn discloses 61M-share stake https://seekingalpha.com/news/1317542-talisman-energy-plus-6_5-percent-ah-as-icahn-discloses-61m-share-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1317542-talisman-energy-plus-6_5-percent-ah-as-icahn-discloses-61m-share-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317522\" data-ts=\"1381181207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JMBA\" target=\"_blank\">JMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317522-jamba-minus-5_8-percent-ah-on-weak-outlook-for-same-store-sales-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jamba -5.8% AH on weak outlook for same-store sales growth</a></h4><ul>     <li>Jamba (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JMBA\" title=\"Jamba, Inc.\">JMBA</a>) <font color=\"red\">-5.8%</font> AH after saying it sees FY 2013 system-wide same store  sales flat to +1%, and store-level margins are seen at 16%-17%, with operating margin of 1%-2%; the company cites weak consumer spending, adverse weather in key markets and increased competition.</li>     <li>Q3 system-wide comparable store sales are expected to drop 3.4%.</li>     <li>Says JambaGo express smoothie units are opening in ~1,000 food  courts across the U.S., bringing total units to more than 1,800.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317522\" data-linked=\"Jamba -5.8% AH on weak outlook for same-store sales growth\" data-tweet=\"$JMBA - Jamba -5.8% AH on weak outlook for same-store sales growth https://seekingalpha.com/news/1317522-jamba-minus-5_8-percent-ah-on-weak-outlook-for-same-store-sales-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/1317522-jamba-minus-5_8-percent-ah-on-weak-outlook-for-same-store-sales-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317472\" data-ts=\"1381179592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317472-nq-mobile-announces-150m-convertible-debt-offering-shares-minus-4_4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile announces $150M convertible debt offering, shares -4.4% AH</a></h4><ul>\n<li>NQ is offering convertible senior notes that are due Oct. 2018, and which can be redeemed by the company in certain circumstances starting Oct. 2016. Underwriters will have the option to purchase an additional $22.5M in notes. (PR)</li>\n<li>NQ only says it will use the proceeds for \"general corporate purposes, including working capital needs and potential acquisitions of complementary businesses.\" The company hasn't been shy about making acquisitions (I, <a href=\"http://ir.nq.com/phoenix.zhtml?c=243152&amp;p=irol-newsArticle&amp;ID=1692569&amp;highlight=\" target=\"_blank\">II</a>) to expand its mobile software/services lineup.</li>\n<li>The offering comes with NQ shares up over 3x YTD. NQ had $15.4M in cash/equivalents at the end of Q2, and no debt.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317472\" data-linked=\"NQ Mobile announces $150M convertible debt offering, shares -4.4% AH\" data-tweet=\"$LKM - NQ Mobile announces $150M convertible debt offering, shares -4.4% AH https://seekingalpha.com/news/1317472-nq-mobile-announces-150m-convertible-debt-offering-shares-minus-4_4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1317472-nq-mobile-announces-150m-convertible-debt-offering-shares-minus-4_4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317422\" data-ts=\"1381177666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSW\" target=\"_blank\">SSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317422-seaspan-offers-5_7m-shares-125m-in-convertible-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaspan offers 5.7M shares, $125M in convertible notes</a></h4><ul>     <li>Seaspan (NYSE:<a href=\"https://seekingalpha.com/symbol/SSW\" title=\"Seaspan Corporation\">SSW</a>) <font color=\"red\">-6.3%</font> AH after announcing <a href=\"http://finance.yahoo.com/news/seaspan-announces-concurrent-public-offerings-200100367.html\" target=\"_blank\">concurrent public offerings</a> of 5.7M common shares and $125M of convertible notes due 2018; in addition to the 5.7M-share offering, a selling shareholder will offer 300K shares.</li>     <li>SSW plans to use net proceeds from the primary offering and convertible note offering for general corporate purposes, which may include funding vessel acquisitions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317422\" data-linked=\"Seaspan offers 5.7M shares, $125M in convertible notes\" data-tweet=\"$SSW - Seaspan offers 5.7M shares, $125M in convertible notes https://seekingalpha.com/news/1317422-seaspan-offers-5_7m-shares-125m-in-convertible-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/1317422-seaspan-offers-5_7m-shares-125m-in-convertible-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317412\" data-ts=\"1381177418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317412-cel-sci-to-sell-shares-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEL-SCI to sell shares, warrants</a></h4><ul>\n<li>CEL-SCI (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/CVM\" title=\"Cel-Sci Corporation\">CVM</a>) announces plans to sell shares and warrants in a public offering.</li>\n<li>Proceeds will go towards general corporate purposes. (PR)</li>\n<li>CVM <font color=\"red\">-17%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317412\" data-linked=\"CEL-SCI to sell shares, warrants\" data-tweet=\"$CVM - CEL-SCI to sell shares, warrants https://seekingalpha.com/news/1317412-cel-sci-to-sell-shares-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/1317412-cel-sci-to-sell-shares-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317392\" data-ts=\"1381177143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHH\" target=\"_blank\">PHH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317392-report-phh-exploring-break-up-and-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: PHH exploring break-up and sale</a></h4><ul><li>PHH Corp. (<a href='https://seekingalpha.com/symbol/PHH' title='PHH Corporation'>PHH</a> <font color='green'>+5.6%</font>) soared into the close as the company is <a href=\"http://finance.yahoo.com/news/exclusive-mortgage-fleet-company-phh-200111461.html\" target=\"_blank\">exploring splitting</a> its mortgage and auto fleet leasing businesses and selling the units, reports Reuters, citing multiple sources.</li><li>The move has been under discussion for several months, they say, and activist investor Orange Capital last month reported a 5% stake in PHH and called for a break-up of the company.</li><li>The short-list of those interested in the mortgage unit would have to include specialty servicers Ocwen (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) and Nationstar (NYSE:<a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"1317392\" data-linked=\"Report: PHH exploring break-up and sale\" data-tweet=\"$PHH $PHH $OCN - Report: PHH exploring break-up and sale https://seekingalpha.com/news/1317392-report-phh-exploring-break-up-and-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/1317392-report-phh-exploring-break-up-and-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317382\" data-ts=\"1381176981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KYTH\" target=\"_blank\">KYTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317382-kythera-biopharmaceuticals-announces-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kythera Biopharmaceuticals announces public offering</a></h4><ul>\n<li>Kythera Biopharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KYTH\" title=\"KYTHERA Biopharmaceuticals\">KYTH</a>) announces a $100M public offering.</li>\n<li>The company will use the proceeds to fund the development and potential commercialization of <a href=\"https://seekingalpha.com/currents/search?query=ATX-101\" target=\"_blank\">ATX-101</a> (the double chin treatment). (PR)</li>\n<li>Now is probably a good time to recall Goldman's <a href=\"https://seekingalpha.com/currents/post/1283472\" target=\"_blank\">warning</a> from September 17: \"<em>KYTH will probably use [ATX-101] data as a catalyst to raise more money</em>.\"</li>\n<li>Shares <font color=\"red\">-5.6%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317382\" data-linked=\"Kythera Biopharmaceuticals announces public offering\" data-tweet=\"$KYTH - Kythera Biopharmaceuticals announces public offering https://seekingalpha.com/news/1317382-kythera-biopharmaceuticals-announces-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1317382-kythera-biopharmaceuticals-announces-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317262\" data-ts=\"1381173808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317262-citron-research-steps-up-assault-on-intuitive-surgical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron Research steps-up assault on Intuitive Surgical</a></h4><ul>\n<li>On the heels of last week's \"follow up\" <a href=\"https://seekingalpha.com/currents/post/1312842\" target=\"_blank\">bear piece</a>, Citron Research pens an open letter to Intuitive Surgical (<a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a> <font color=\"green\">+4.5%</font>).</li>\n<li>Citron alleges \"gross misuse\" of the FDA's MAUDE dataset (the subject of last week's report) in a chart published on ISRG's corporate website.</li>\n<li>Here is one of Citron's \"stand out\" points: ISRG's \"computation and graphing comparison of MAUDE adverse event rates is misleading [because] it is extremely unlikely that FDA AERs on surgeries outside the U.S. will ever be filed. Nevertheless, [ISRG] chooses as a denominator 'completed worldwide surgical procedures.'\"</li>\n<li>Citron also says September's MAUDE reports show \"another 102 injury-type reports and another four death-type reports, [exceeding] August's record high, which was itself four times any previous reporting period in the company's history.\"</li>\n<li><a href=\"http://www.citronresearch.com/citron-updates-intuitive-surgical-price-target-to-200/\" target=\"_blank\">Full letter</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317262\" data-linked=\"Citron Research steps-up assault on Intuitive Surgical\" data-tweet=\"$ISRG - Citron Research steps-up assault on Intuitive Surgical https://seekingalpha.com/news/1317262-citron-research-steps-up-assault-on-intuitive-surgical?source=tweet\" data-url=\"https://seekingalpha.com/news/1317262-citron-research-steps-up-assault-on-intuitive-surgical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317172\" data-ts=\"1381171669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HFC\" target=\"_blank\">HFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317172-hollyfrontier-downgraded-at-imperial-capital-refiners-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HollyFrontier downgraded at Imperial Capital, refiners fall</a></h4><ul>     <li>Refining stocks are lower as HollyFrontier (<a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"red\">-0.7%</font>) is hit with a <a href=\"http://www.streetinsider.com/Analyst+Comments/Imperial+Capital+Downgrades+HollyFrontier+%28HFC%29+to+In-Line/8755552.html\" target=\"_blank\">downgrade</a> from Imperial Capital, which dropped its rating to In-Line from Outperform, reduces its price target to $41 from $49, and cuts its 2013 EPS estimate to $3.83 from $4.83 and 2014 EPS estimate to $3.50 from $4.00.</li>     <li>The firm sees continued contraction in refining margins and crude price differentials, especially as the southern leg of the Keystone XL pipeline commences operation later this month.</li>     <li>Other refiners: <a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"red\">-0.6%</font>, TSO <font color=\"red\">-0.8%</font>, <a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"red\">-1.4%</font>, <a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"red\">-1.5%</font>, <a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"red\">-1.4%</font>, <a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"red\">-2.5%</font>, <a href=\"https://seekingalpha.com/symbol/CVI\" title=\"CVR Energy, Inc.\">CVI</a> <font color=\"red\">-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317172\" data-linked=\"HollyFrontier downgraded at Imperial Capital, refiners fall\" data-tweet=\"$HFC $HFC $VLO - HollyFrontier downgraded at Imperial Capital, refiners fall https://seekingalpha.com/news/1317172-hollyfrontier-downgraded-at-imperial-capital-refiners-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1317172-hollyfrontier-downgraded-at-imperial-capital-refiners-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317142\" data-ts=\"1381170268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317142-ascendiant-capital-initiates-galectin-therapeutics-at-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascendiant Capital initiates Galectin Therapeutics at Buy</a></h4><ul>\n<li>Ascendiant Capital Markets <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/10/3971452/update-ascendiant-capital-initiates-coverage-on-galectin\" target=\"_blank\">starts</a> Galectin Therapeutics (<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"green\">+6.8%</font>) at Buy, calling the company \"an intriguing speculative small cap investment story.\"</li>\n<li>Price target is $13, representing an <font color=\"green\">18%</font> upside from Friday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317142\" data-linked=\"Ascendiant Capital initiates Galectin Therapeutics at Buy\" data-tweet=\"$GALT - Ascendiant Capital initiates Galectin Therapeutics at Buy https://seekingalpha.com/news/1317142-ascendiant-capital-initiates-galectin-therapeutics-at-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1317142-ascendiant-capital-initiates-galectin-therapeutics-at-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317102\" data-ts=\"1381169145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTM-OLD\" target=\"_blank\">QTM-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317102-quantum-jumps-company-reportedly-on-the-block\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quantum jumps, company reportedly on the block</a></h4><ul>\n<li>DealReporter states Quantum (<a href=\"https://seekingalpha.com/symbol/QTM-OLD\" title=\"Quantum Corporation\">QTM-OLD</a> <font color=\"green\">+5%</font>) has has <a href=\"https://twitter.com/thenotablecalls/status/387262271899967490\" target=\"_blank\">received a buyout offer</a>, and has initiated a sale process in response.</li>\n<li>Activist investor Starboard Value has reportedly been pressuring the low-end storage hardware/software vendor to evaluate ts options. Starboard took a <a href=\"https://seekingalpha.com/currents/post/636891\" target=\"_blank\">double-digit stake</a> in Quantum last year, and <a href=\"http://online.wsj.com/article/PR-CO-20130514-913632.html\" target=\"_blank\">secured a board seat</a> five months ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317102\" data-linked=\"Quantum jumps, company reportedly on the block\" data-tweet=\"$QTM-OLD - Quantum jumps, company reportedly on the block https://seekingalpha.com/news/1317102-quantum-jumps-company-reportedly-on-the-block?source=tweet\" data-url=\"https://seekingalpha.com/news/1317102-quantum-jumps-company-reportedly-on-the-block\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317092\" data-ts=\"1381168980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORV\" target=\"_blank\">CORV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317092-cardiome-pharma-reports-publication-of-observational-brinavess-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardiome Pharma reports publication of observational Brinavess data</a></h4><ul>\n<li>Shares of Cardiome Pharma (CRME <font color=\"green\">+18.2%</font>) are surging on huge volume.</li>\n<li>Data from an observational, retrospective study shows 70% of 251 recent-onset AF patients who received <a href=\"https://seekingalpha.com/currents/search?query=brinavess\" target=\"_blank\">Brinavess</a> treatments responded with conversion to sinus rhythm. Median time was 11 minutes.</li>\n<li>Median ER time for converted Brinavess patients was 6.5 hours.</li>\n<li>\"The finding that 75% of successfully  treated BRINAVESS patients remained in normal sinus rhythm after a one  year follow-up period - was an extremely interesting and important  finding that requires further investigation,\" the study's principal investigator notes. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1317092\" data-linked=\"Cardiome Pharma reports publication of observational Brinavess data\" data-tweet=\"$CORV - Cardiome Pharma reports publication of observational Brinavess data https://seekingalpha.com/news/1317092-cardiome-pharma-reports-publication-of-observational-brinavess-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1317092-cardiome-pharma-reports-publication-of-observational-brinavess-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317062\" data-ts=\"1381168444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317062-exone-higher-fbr-comments-on-bullish-management-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne higher; FBR comments on bullish management talks</a></h4><ul>     <li>FBR's <a href=\"http://blogs.barrons.com/techtraderdaily/2013/10/07/exone-fbr-says-buy-on-growing-margins-sales-interest-from-bmw-tesla/\" target=\"_blank\">Ajay Kerjriwal</a>, who is reiterating an Outperform and $75 PT on ExOne (<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> <font color=\"green\">+7.1%</font>), says management indicated at investor meetings it's confident the 3D printer maker can achieve 40%-50% organic revenue growth over the next several years.</li>     <li>Also mentioned: ExOne is working with auto industry clients such as BMW and Tesla to create products such as \"air-cooled systems that have intricate channels, combustion-related parts, and suspension arms.\" Mass-production for some parts is expected to start in 2-3 years.</li>     <li>Kerkriwal adds management's commentary \"suggests strong interest from large industrial companies in establishing JVs/partnership for product/process development,\" and praises the \"competitive superiority\" of ExOne's technology.</li>     <li>ExOne has had a roller-coaster ride this year. Though shares are still <font color=\"green\">up 164%</font> from a Feb. IPO price of $18, they're <font color=\"red\">down 40%</font> from an Aug. high of $78.80.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317062\" data-linked=\"ExOne higher; FBR comments on bullish management talks\" data-tweet=\"$XONE - ExOne higher; FBR comments on bullish management talks https://seekingalpha.com/news/1317062-exone-higher-fbr-comments-on-bullish-management-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/1317062-exone-higher-fbr-comments-on-bullish-management-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317022\" data-ts=\"1381167007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317022-wells-fargo-weighs-in-on-cell-therapeutics-myelofibrosis-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo weighs in on Cell Therapeutics&#39; myelofibrosis treatment</a></h4><ul><li>Wells Fargo's Brian Abrahams says Cell Therapeutics' (<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+18.2%</font>) <a href=\"https://seekingalpha.com/currents/search?query=pacritinib\" target=\"_blank\">pacritinib</a> has a \"niche market\" and <a href=\"http://www.streetinsider.com/Analyst+Comments/Wells+Doesn%27t+See+Cell+Therapeutics%27+%28CTIC%29+Pacritinib+as+Threat+to+Incyte%27s+%28INCY%29+Jakafi/8755690.html\" target=\"_blank\">may not pose</a> a meaningful threat to Incyte's (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-3.6%</font>) myelofibrosis treatment <a href=\"https://seekingalpha.com/currents/search?query=jakafi\" target=\"_blank\">Jakafi</a>. In August, INCY guided for FY13 Jakafi sales of $210-225M.</li><li>Abrahams' comments come on the heels of CTIC's announcement that it has <a href=\"https://seekingalpha.com/currents/post/1316002\" target=\"_blank\">come to an agreement</a> with the FDA on the SPA for a second Phase 3 trial of pacritinib.</li><li>Related: Jakafi may have <a href=\"https://seekingalpha.com/currents/post/1293562\" target=\"_blank\">more potential</a> in polycythemia vera than myelofibrosis.<br></li></ul><div class=\"tiny-share-widget\" data-id=\"1317022\" data-linked=\"Wells Fargo weighs in on Cell Therapeutics&#39; myelofibrosis treatment\" data-tweet=\"$CTIC $CTIC $INCY - Wells Fargo weighs in on Cell Therapeutics&#39; myelofibrosis treatment https://seekingalpha.com/news/1317022-wells-fargo-weighs-in-on-cell-therapeutics-myelofibrosis-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1317022-wells-fargo-weighs-in-on-cell-therapeutics-myelofibrosis-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316992\" data-ts=\"1381166169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316992-halozyme-slips-as-ubs-questions-herceptin-visibility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme slips as UBS questions Herceptin visibility</a></h4><ul><li>Weakness in shares of Halozyme Therapeutics (<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='red'>-3.2%</font>)&nbsp;may be attributable to UBS' Matthew Roden, who notes that tracking the use of <a href=\"https://seekingalpha.com/currents/search?query=rHuPH20\" target=\"_blank\">rHuPH20</a> in <a href=\"https://seekingalpha.com/currents/search?query=herceptin\" target=\"_blank\">Herceptin</a> will be <a href=\"http://www.streetinsider.com/Analyst+Comments/Halozyme+%28HALO%29+Hyaluronidase+Use+in+Herceptin+Will+be+Difficult+to+Track+-+UBS/8755311.html\" target=\"_blank\">difficult</a>, as Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-0.4%</font>)  may not disclose the split and royalty information for the breast cancer treatment.&nbsp;</li><li>See also: Roche <a href=\"https://seekingalpha.com/currents/post/1256542\" target=\"_blank\">gets authorization</a> for sub-Q Herceptin</li></ul><div class=\"tiny-share-widget\" data-id=\"1316992\" data-linked=\"Halozyme slips as UBS questions Herceptin visibility\" data-tweet=\"$HALO $HALO $RHHBY - Halozyme slips as UBS questions Herceptin visibility https://seekingalpha.com/news/1316992-halozyme-slips-as-ubs-questions-herceptin-visibility?source=tweet\" data-url=\"https://seekingalpha.com/news/1316992-halozyme-slips-as-ubs-questions-herceptin-visibility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316982\" data-ts=\"1381165615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316982-psivida-up-sharply-after-bullish-article-predicts-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">pSivida up sharply after bullish article predicts takeover</a></h4><ul>\n<li>pSivida (PSDV <font color=\"green\">+8.4%</font>) trades markedly higher on heavy volume.</li>\n<li>The shares look to be getting a lift from SA contributor Bob's Stocks, who says the stock is worth \"way north of $15/share\" based on the company's share of revenues from the DME treatment Iluvien.</li>\n<li>The author is also \"<a href=\"https://seekingalpha.com/article/1731522-psivida-corporation-strong-takeover-target-october-17th-pdufa-date-make-it-a-buy\" target=\"_blank\">95% sure</a>\" that the company's upcoming (October 17) PDUFA meeting with the FDA will go well and calls the polymide tube's chances of U.S. approval \"a slam dunk.\"</li>\n<li>Bob's Stocks also thinks the company is \"a huge takeover target for big pharma who want to dominate the ocular market.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316982\" data-linked=\"pSivida up sharply after bullish article predicts takeover\" data-tweet=\"$EYPT - pSivida up sharply after bullish article predicts takeover https://seekingalpha.com/news/1316982-psivida-up-sharply-after-bullish-article-predicts-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/1316982-psivida-up-sharply-after-bullish-article-predicts-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316962\" data-ts=\"1381164507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316962-deckers-outdoor-lower-after-otr-global-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Outdoor lower after OTR Global warning</a></h4><ul> <li>Shares of Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='red'>-6.1%</font>) crumble after OTR Global warns on sales trends for the company's Ugg brand.</li> <li>A couple of eagle-eyed retail analysts <a href=\"https://twitter.com/AshleyLutz/status/387242443063959552\" target=\"_blank\">note</a> the company is now using a sheepskin substitute called <a href=\"http://www.uggaustralia.com/world-of-ugg-craftsmanship.html\" target=\"_blank\">UGGpure</a> for some of its boots.</li><li>The ploy could help margins, but also risks denting the brand's reputation.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1316962\" data-linked=\"Deckers Outdoor lower after OTR Global warning\" data-tweet=\"$DECK - Deckers Outdoor lower after OTR Global warning https://seekingalpha.com/news/1316962-deckers-outdoor-lower-after-otr-global-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/1316962-deckers-outdoor-lower-after-otr-global-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316952\" data-ts=\"1381164402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316952-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='green'>+57%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/ALTI' title='Altair Nanotechnologies Inc.'>ALTI</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ANV' title='Allied Nevada Gold Corp'>ANV</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ARCW' title='ARC Group Worldwide, Inc.'>ARCW</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EFUT' title='e-Future Information Technology Inc.'>EFUT</a> <font color='green'>+20%</font>.</li><li><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='red'>-47%</font>. <a href='https://seekingalpha.com/symbol/ACFN' title='Acorn Energy, Inc.'>OTC:ACFN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/EVK' title='Ever-Glory International Group, Inc'>EVK</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SKBI' title='Skystar Bio - Pharmaceutical Company'>SKBI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LQDT' title='Liquidity Services, Inc.'>LQDT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MTRN' title='Materion Corporation'>MTRN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IFNY' title='Infinity Energy Resources, Inc.'>OTCPK:IFNY</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316952\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$VISN $GWPH $JRJC - Midday Gainers / Losers https://seekingalpha.com/news/1316952-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1316952-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316942\" data-ts=\"1381164154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FST\" target=\"_blank\">FST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316942-forest-oils-asset-sale-raises-valuation-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forest Oil&#39;s asset sale raises valuation concerns</a></h4><ul>     <li>The downdraft in shares of Forest Oil (<a href=\"https://seekingalpha.com/symbol/FST\" title=\"Forest Oil Corporation\">FST</a> <font color=\"red\">-6.1%</font>) extends to a second day after Friday's <a href=\"https://seekingalpha.com/currents/post/1314702\" target=\"_blank\">disappointing reaction</a> to the <a href=\"https://seekingalpha.com/currents/post/1313642\" target=\"_blank\">$1B sale</a> of its Texas Panhandle assets.</li>     <li>A new Seeking Alpha blog says the recent deal has \"left the cupboard looking bare... With high leverage and a  multiple that doesn't match its asset quality, the <a href=\"https://seekingalpha.com/embargo/1731452?app=p&amp;source=email_rt_pro_article_title\" target=\"_blank\">shares could drop  25-45% more</a>.\"</li>     <li>With only ~28K net acres in the Eagle Ford and east Texas economics subdued by low gas prices, the thinking is that FST will need to eventually pursue acquisitions to bolster its portfolio.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316942\" data-linked=\"Forest Oil&#39;s asset sale raises valuation concerns\" data-tweet=\"$FST - Forest Oil&#39;s asset sale raises valuation concerns https://seekingalpha.com/news/1316942-forest-oils-asset-sale-raises-valuation-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/1316942-forest-oils-asset-sale-raises-valuation-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316932\" data-ts=\"1381164090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITK\" target=\"_blank\">MITK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316932-mitek-rallies-after-announcing-partnership-with-experian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitek rallies after announcing partnership with Experian</a></h4><ul>     <li>Mitek (<a href=\"https://seekingalpha.com/symbol/MITK\" title=\"Mitek Systems Inc.\">MITK</a> <font color=\"green\">+3.7%</font>) and Experian (<a href=\"https://seekingalpha.com/symbol/EXPGF\" title=\"Experian plc\">OTCQX:EXPGF</a>, <a href=\"https://seekingalpha.com/symbol/EXPGY\" title=\"Experian plc ADR\">OTCQX:EXPGY</a> - a top financial information/credit data provider) are partnering to offer a solution that eliminates manual data entry for consumers looking to set up bank accounts using mobile devices. (PR)</li>     <li>The solution combines Mitek's <a href=\"http://www.miteksystems.com/solutions/banking/mpao\" target=\"_blank\">Mobile Photo Account Opening</a> product with Experian's fraud prevention/authentication services. Consumers can upload front/back pictures of their driver's licenses taken with a phone's camera to provide banks with needed info, in lieu of typing the info using a phone's keyboard.</li>     <li>Though below its June highs, Mitek is <strong><font color=\"green\">up 67%</font></strong> YTD following a rough 2012. 24.4% of the float was shorted as of Sep. 13.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316932\" data-linked=\"Mitek rallies after announcing partnership with Experian\" data-tweet=\"$MITK $MITK $EXPGF - Mitek rallies after announcing partnership with Experian https://seekingalpha.com/news/1316932-mitek-rallies-after-announcing-partnership-with-experian?source=tweet\" data-url=\"https://seekingalpha.com/news/1316932-mitek-rallies-after-announcing-partnership-with-experian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316922\" data-ts=\"1381164087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316922-deutsche-says-sarepta-fair-value-could-exceed-200-per-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche says Sarepta fair value could exceed $200 per share</a></h4><ul>\n<li>Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+1.9%</font>) may be up <font color=\"green\">100%</font> YTD, but that doesn't mean it can't rally another 294% or so, Deutsche's Robyn Karnauskas thinks.</li>\n<li>Karnauskas \u2014 whose price target is currently $71 \u2014 <a href=\"http://www.streetinsider.com/Analyst+Comments/Sarepta+%28SRPT%29+Fair+Value+as+High+as+%24213+-+Deutsche+Bank/8755344.html\" target=\"_blank\">further highlights</a> the apparent efficacy disparity between <a href=\"https://seekingalpha.com/currents/search?query=drisapersen\" target=\"_blank\">drisapersen</a> and <a href=\"https://seekingalpha.com/currents/search?query=eteplirsen\" target=\"_blank\">eteplirsen</a> noting that patients taking eteplirsen saw \"stabilization in 6MWD as early as 24 weeks [and remained] stable even at 96 weeks.\"</li>\n<li>Here's the real kicker though: \"We could see FV in $98-$125 range if we assume 100% probability to  Eteplirsen and 80-100% market share in treated patients. If we assume  100% probability to their other exon program, we get to SRPT FV of <strong> $213/share</strong>.\" (emphasis added)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316922\" data-linked=\"Deutsche says Sarepta fair value could exceed $200 per share\" data-tweet=\"$SRPT - Deutsche says Sarepta fair value could exceed $200 per share https://seekingalpha.com/news/1316922-deutsche-says-sarepta-fair-value-could-exceed-200-per-share?source=tweet\" data-url=\"https://seekingalpha.com/news/1316922-deutsche-says-sarepta-fair-value-could-exceed-200-per-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316802\" data-ts=\"1381162430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWCH\" target=\"_blank\">DWCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316802-datawatch-jumps-following-craig-hallum-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datawatch jumps following Craig-Hallum coverage launch</a></h4><ul>     <li>CH has started coverage on Datawatch (<a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+6.9%</font>) with a Buy and $37 PT.</li>     <li>The launch comes six weeks after Datawatch <a href=\"https://seekingalpha.com/currents/post/1249992\" target=\"_blank\">closed its $50M acquisition</a> of data visualization/analytics software vendor Panopticon.</li>     <li>Shares now <strong><font color='green'>+117%</font></strong> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316802\" data-linked=\"Datawatch jumps following Craig-Hallum coverage launch\" data-tweet=\"$DWCH - Datawatch jumps following Craig-Hallum coverage launch https://seekingalpha.com/news/1316802-datawatch-jumps-following-craig-hallum-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1316802-datawatch-jumps-following-craig-hallum-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316772\" data-ts=\"1381161454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUQ\" target=\"_blank\">AUQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316772-aurico-osisko-upgraded-at-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AuRico, Osisko upgraded at Credit Suisse</a></h4><ul>     <li>AuRico Gold (<a href=\"https://seekingalpha.com/symbol/AUQ\" title=\"AuRico Gold\">AUQ</a> <font color=\"green\">+3.2%</font>) and Osisko Mining (OSKFF.PK <font color=\"green\">+6.2%</font>) are <a href=\"http://business.financialpost.com/2013/10/07/osisko-and-aurico-upgraded-at-credit-suisse/\" target=\"_blank\">upgraded</a> to Outperform from Neutral by Credit Suisse.</li>     <li>The firm notes that AUQ has changed management, transformed its asset base divesting higher  cost mines to lower costs mines, revised expectations, and has  delivered against targets; market hesitation  remains, providing an attractive entry point.</li>     <li>Osisko's Malartic project is progressing to full production, costs are  improving to levels in line with the sector average, liquidity is no  longer an immediate concern, and its valuation remains attractive.</li>     <li>Despite the upgrade, the firm cuts its price target for AUQ to $5 from $5.50; it raises its target for Osisko to $7 from $6.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316772\" data-linked=\"AuRico, Osisko upgraded at Credit Suisse\" data-tweet=\"$AUQ $AUQ $OBNNF - AuRico, Osisko upgraded at Credit Suisse https://seekingalpha.com/news/1316772-aurico-osisko-upgraded-at-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/1316772-aurico-osisko-upgraded-at-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316732\" data-ts=\"1381159999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LQDT\" target=\"_blank\">LQDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316732-liquidity-services-dives-on-two-notch-bofa-merrill-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liquidity Services dives on two-notch BofA/Merrill downgrade</a></h4><ul>     <li>Easy come, easy go: Less than a month after giving Liquidity Services (<a href=\"https://seekingalpha.com/symbol/LQDT\" title=\"Liquidity Services, Inc.\">LQDT</a> <font color=\"red\">-9.6%</font>) a <a href=\"https://seekingalpha.com/currents/post/1273942\" target=\"_blank\">two-notch upgrade</a> to Buy from Underperform, BofA/Merrill's Nat Schindler has <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/10/3971254/update-bank-of-america-bank-of-america-downgrades-liquid\" target=\"_blank\">done the opposite</a>.</li>     <li>Schindler observes Liquidity  reported Sep. gross merchandise volume (GMV) of $77M, -11% Y/Y. Though that figure means the salvage auction site had FQ4 (Sep. quarter) GMV of $250M (in-line with BofA/Merrill's estimate), Schindler was expecting a return to positive growth following increases of 7.1% and 14.5% in July and August.</li>     <li>Liquidity previously forecast FQ4 GMV of $200M-$225M. Shares <font color=\"red\">-28%</font> YTD and not far removed from a 52-week low of $27.26.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316732\" data-linked=\"Liquidity Services dives on two-notch BofA/Merrill downgrade\" data-tweet=\"$LQDT - Liquidity Services dives on two-notch BofA/Merrill downgrade https://seekingalpha.com/news/1316732-liquidity-services-dives-on-two-notch-bofa-merrill-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1316732-liquidity-services-dives-on-two-notch-bofa-merrill-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316622\" data-ts=\"1381157706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKT\" target=\"_blank\">PKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316622-procera-higher-after-announcing-asia-pac-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Procera higher after announcing Asia-Pac order</a></h4><ul>\n<li>Procera (<a href=\"https://seekingalpha.com/symbol/PKT\" title=\"Procera Networks, Inc\">PKT</a> <font color=\"green\">+3.4%</font>) has \"received a first-time multi-million dollar order\" from an unnamed major Asia-Pac mobile carrier for the company's deep packet inspection hardware. Procera says the orders is the first placed on a \"multi-year framework contract,\" and the this from a major Asia-Pac carrier in the last five months. (PR)</li>\n<li>Rival Allot saw its shares jump last week after <a href=\"https://seekingalpha.com/currents/post/1310662\" target=\"_blank\">announcing a deal</a> with a U.S. cloud services provider. Following its Q2 report, Procera disclosed it had <a href=\"https://seekingalpha.com/currents/post/1204402\" target=\"_blank\">received a $20M order</a> from a \"mega-carrier\" that will ramp in Q3.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316622\" data-linked=\"Procera higher after announcing Asia-Pac order\" data-tweet=\"$PKT - Procera higher after announcing Asia-Pac order https://seekingalpha.com/news/1316622-procera-higher-after-announcing-asia-pac-order?source=tweet\" data-url=\"https://seekingalpha.com/news/1316622-procera-higher-after-announcing-asia-pac-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316612\" data-ts=\"1381157641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANV\" target=\"_blank\">ANV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316612-allied-nevada-plus-16-percent-on-record-gold-production-sales-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allied Nevada +16% on record gold production, sales results</a></h4><ul>     <li>Allied Nevada (<a href=\"https://seekingalpha.com/symbol/ANV\" title=\"Allied Nevada Gold Corp\">ANV</a> <font color=\"green\">+16.1%</font>) says it achieved <a href=\"http://finance.yahoo.com/news/allied-nevada-achieved-record-gold-123000933.html\" target=\"_blank\">record gold production and sales</a> in Q3.</li>     <li>Its Hycroft mine produced a record 52,198 oz. of gold and  184,070 oz. of silver in Q3, and ANV sold a record 52,713 oz. of gold and 184,082 oz. of silver; ANV believes it is on track to achieve full-year production and sales guidance of 175K-200K oz. of gold and 0.9M-1.1M oz. of silver in 2013.</li>     <li>ANV's new 21.5K gal/minute Merrill-Crowe plant began commissioning at the end of Q3; the silver sales ratio is expected to increase with the exclusive use of  the new Merrill-Crowe plant from ~3.5 oz. of silver for each oz. of gold produced to in excess of 6:1.</li>\n<li>Shares are upgraded to Outperform from Sector Perform at Scotia Capital after ANV released the numbers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316612\" data-linked=\"Allied Nevada +16% on record gold production, sales results\" data-tweet=\"$ANV - Allied Nevada +16% on record gold production, sales results https://seekingalpha.com/news/1316612-allied-nevada-plus-16-percent-on-record-gold-production-sales-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1316612-allied-nevada-plus-16-percent-on-record-gold-production-sales-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316592\" data-ts=\"1381156785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACFN\" target=\"_blank\">ACFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316592-acorn-energy-minus-21-percent-on-updated-outlook-impairment-charge-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorn Energy -21% on updated outlook, impairment charge, offering</a></h4><ul>     <li>Acorn Energy (<a href='https://seekingalpha.com/symbol/ACFN' title='Acorn Energy, Inc.'>OTC:ACFN</a> <font color='red'>-21.4%</font>) plunges after disclosing its <a href=\"http://www.sec.gov/Archives/edgar/data/880984/000114420413054094/v356691_8k.htm\" target=\"_blank\">financial outlook</a>, saying revenue and earnings performance for Q3 and full-year 2013 and 2014 will end materially below expectations.</li>     <li>ACFN will record an impairment charge as a result of write-downs of goodwill and other intangibles, and will record a restructuring charge with respect to its  OmniMetrix subsidiary; the moves likely will have a material impact on Q3 operational results.</li>     <li>Also, ACFN files for a ~$15M <a href=\"http://www.sec.gov/Archives/edgar/data/880984/000114420413054097/v356742_424b5.htm\" target=\"_blank\">common stock offering</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316592\" data-linked=\"Acorn Energy -21% on updated outlook, impairment charge, offering\" data-tweet=\"$ACFN - Acorn Energy -21% on updated outlook, impairment charge, offering https://seekingalpha.com/news/1316592-acorn-energy-minus-21-percent-on-updated-outlook-impairment-charge-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1316592-acorn-energy-minus-21-percent-on-updated-outlook-impairment-charge-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316562\" data-ts=\"1381156227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316562-invensense-higher-following-bullish-evercore-craig-hallum-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense higher following bullish Evercore, Craig-Hallum notes</a></h4><ul>\n<li>After making Asian supply chain checks, Evercore's <a href=\"http://blogs.barrons.com/techtraderdaily/2013/10/07/this-morning-50-target-on-twitter-wave-of-aapl-enthusiasm-pondering-pcs/\" target=\"_blank\">Patrick Wang</a> says he believes InvenSense's (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+3.7%</font>) motion sensors are now \"ramping at Apple.\" Shares sold off last month after iPhone 5S teardowns <a href=\"https://seekingalpha.com/currents/post/1291192\" target=\"_blank\">failed to uncover </a>InvenSense sensors.</li>\n<li>Meanwhile, Craig-Hallum is talking up InvenSense's non-Apple design win activity. The firm thinks InvenSense has been designed into Amazon's <a href=\"https://seekingalpha.com/currents/post/1297532\" target=\"_blank\">latest Kindle Fires</a> and Samsung's Galaxy Gear smartwatch (<a href=\"https://seekingalpha.com/currents/post/1262722\" target=\"_blank\">previous</a>), among other products.</li>\n<li>26.7% of the float was shorted as of Sep. 13.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316562\" data-linked=\"InvenSense higher following bullish Evercore, Craig-Hallum notes\" data-tweet=\"$INVN - InvenSense higher following bullish Evercore, Craig-Hallum notes https://seekingalpha.com/news/1316562-invensense-higher-following-bullish-evercore-craig-hallum-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/1316562-invensense-higher-following-bullish-evercore-craig-hallum-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316542\" data-ts=\"1381155922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTRN\" target=\"_blank\">MTRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316542-materion-minus-8_7-percent-after-issuing-q3-warning-but-sees-strong-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Materion -8.7% after issuing Q3 warning but sees strong Q4</a></h4><ul>     <li>Materion (<a href=\"https://seekingalpha.com/symbol/MTRN\" title=\"Materion Corporation\">MTRN</a> <font color=\"red\">-8.7%</font>) issues downside guidance for Q3, seeing EPS of ~$0.20 vs. $0.39 consensus estimate, and says shipments of certain high-margin beryllium-based defense and nuclear science as well as defense optics orders have been delayed.</li>     <li>MTRN also issues guidance for Q4, seeing EPS well ahead of Q3 and the strongest of the year, exceeding Q2's $0.43.</li>     <li>MTRN plans to take additional facility and product line rationalization actions during Q4, which will result in a charge of up to $0.15/share but should favorably impact 2014 performance by up to $0.30/share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316542\" data-linked=\"Materion -8.7% after issuing Q3 warning but sees strong Q4\" data-tweet=\"$MTRN - Materion -8.7% after issuing Q3 warning but sees strong Q4 https://seekingalpha.com/news/1316542-materion-minus-8_7-percent-after-issuing-q3-warning-but-sees-strong-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1316542-materion-minus-8_7-percent-after-issuing-q3-warning-but-sees-strong-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316452\" data-ts=\"1381154042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316452-junior-gold-miners-etf-hit-by-liongold-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Junior gold miners ETF hit by LionGold plunge</a></h4><ul>\n<li>The Junior Gold Miners ETF (<a href=\"https://seekingalpha.com/symbol/gdxj\" title=\"Market Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"red\">-0.4%</font>) opened sharply lower (but has since recovered) after LionGold <a href=\"http://online.wsj.com/news/articles/SB10001424052702304171804579120192108848258\" target=\"_blank\">plunged 71% overnight</a> in Singapore amid the deflating of a mini-small-cap bubble. At 4.78% of AUM, LionGold was GDXJ's largest holding at last report.</li>\n<li>The decline had begun on Friday and the exchange suspended trading in LionGold and two other names citing concerns market participants might not be \"fully informed.\" The dive accelerated after trading was re-opened.</li>\n<li>The iShares MSCI Singapore Small-Cap ETF (<a href=\"https://seekingalpha.com/symbol/ewss\" title=\"iShares MSCI Singapore Small-Cap ETF\">EWSS</a> <font color=\"red\">-3.8%</font>).</li>\n<li>Thus far there doesn't appear to be much spillover into the blue-chip market (<a href=\"https://seekingalpha.com/symbol/ews\" title=\"iShares MSCI Singapore ETF\">EWS</a> <font color=\"red\">-0.2%</font>) - known mostly for its REITs and other dividend payers.</li>\n<li>Other gold-mining ETFs: <a href=\"https://seekingalpha.com/symbol/gdx\" title=\"Market Vectors Gold Miners ETF\">GDX</a>, <a href=\"https://seekingalpha.com/symbol/gdxj\" title=\"Market Vectors Junior Gold Miners ETF\">GDXJ</a>, <a href=\"https://seekingalpha.com/symbol/gldx\" title=\"Global X Gold Explorers ETF\">GLDX</a>, <a href=\"https://seekingalpha.com/symbol/psau\" title=\"PowerShares Global Gold and Precious Metals Portfolio ETF\">PSAU</a>, <a href=\"https://seekingalpha.com/symbol/nugt\" title=\"Direxion Daily Gold Miners Bull 3x Shares ETF\">NUGT</a>, <a href=\"https://seekingalpha.com/symbol/dust\" title=\"Direxion Daily Gold Miners Bear 3x Shares ETF\">DUST</a>, <a href=\"https://seekingalpha.com/symbol/gggg\" title=\"Global X Pure Gold Miners ETF\">GGGG</a>, <a href=\"https://seekingalpha.com/symbol/ring\" title=\"iShares MSCI Global Gold Miners ETF\">RING</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316452\" data-linked=\"Junior gold miners ETF hit by LionGold plunge\" data-tweet=\"$GDXJ $EWSS $EWS - Junior gold miners ETF hit by LionGold plunge https://seekingalpha.com/news/1316452-junior-gold-miners-etf-hit-by-liongold-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/1316452-junior-gold-miners-etf-hit-by-liongold-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316392\" data-ts=\"1381152544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316392-bangkok-slips-manila-rises-in-cautious-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bangkok slips, Manila rises in cautious trade</a></h4><ul>\n<li>Thai (<a href=\"https://seekingalpha.com/symbol/thd\" title=\"iShares MSCI Thailand Capped ETF\">THD</a>, <a href=\"https://seekingalpha.com/symbol/tf\" title=\"Thai Capital Fund\">TF</a>, <a href=\"https://seekingalpha.com/symbol/ttf\" title=\"Thai Fund\">TTF</a>) and Philippine (<a href=\"https://seekingalpha.com/symbol/ephe\" title=\"iShares MSCI Philippines ETF\">EPHE</a>) shares are the only thing stirring in Southeast Asia, as cautious trading predominates amid worries over the U.S. government shutdown and debt ceiling.</li>\n<li>SET <font color=\"red\">-0.9%</font>\n</li>\n<li>PSEi <font color=\"green\">+0.8%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316392\" data-linked=\"Bangkok slips, Manila rises in cautious trade\" data-tweet=\"$THD $TF-OLD $TTF - Bangkok slips, Manila rises in cautious trade https://seekingalpha.com/news/1316392-bangkok-slips-manila-rises-in-cautious-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/1316392-bangkok-slips-manila-rises-in-cautious-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316372\" data-ts=\"1381152397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316372-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>     <li>BlackBerry (BBRY) has been upgraded to Neutral by Macquarie following a <a href=\"https://seekingalpha.com/currents/post/1315602\" target=\"_blank\">weekend report</a> indicating the company is in talks to sell part or all of the company to Cisco, Google, SAP, and others. Shares <font color=\"green\">+4%</font> premarket.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/IBM\" title=\"International Business Machines Corporation\">IBM</a> and Informatica (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFA\" title=\"Informatica Corporation\">INFA</a>) have been cut to Equal Weight by Barclays. IBM <font color=\"red\">-1.4%</font>.</li>     <li>Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) has been started with a Buy and $50 PT by SunTrust ahead of its IPO. The PT implies a $25B valuation.</li>     <li>Infosys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFY\" title=\"Infosys Limited, Inc.\">INFY</a>) has been upgraded to Buy by BNP Paribas.</li>     <li>MaxLinear (NYSE:<a href=\"https://seekingalpha.com/symbol/MXL\" title=\"MaxLinear, Inc.\">MXL</a>) has been upgraded to Outperform by JMP following news the chipmaker <a href=\"https://seekingalpha.com/currents/post/1315442\" target=\"_blank\">has settled</a> its patent dispute with Silicon Labs.</li>     <li>Citrix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a>) has been upgraded to Overweight by Barclays.</li>     <li>Splunk (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPLK\" title=\"Splunk Inc.\">SPLK</a>) has received a two-notch downgrade to Underperform by Credit Agricole. <a href=\"https://seekingalpha.com/currents/post/1310302\" target=\"_blank\">Needham</a> cut shares to Hold last week. Shares <font color=\"red\">-2.3%</font>.</li>     <li>PT Telekomunikasi Indonesia (NYSE:<a href=\"https://seekingalpha.com/symbol/TLK\" title=\"P.T. Telekomunikasi Indonesia\">TLK</a>) has been cut to Neutral by Credit Suisse.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316372\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$BB $BB $IBM - A roundup of tech ratings changes https://seekingalpha.com/news/1316372-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1316372-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316332\" data-ts=\"1381151545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316332-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OUTR' title='Outerwall Inc.'>OUTR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='red'>-52%</font>. <a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1316332\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$GWPH $OUTR $CTIC - Premarket Gainers / Losers https://seekingalpha.com/news/1316332-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1316332-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316232\" data-ts=\"1381149703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316232-apricus-biosciences-jumps-on-german-phase-approval-for-vitaros\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Biosciences jumps on German phase approval for Vitaros</a></h4><ul>     <li>Apricus Biosciences (APRI) gets national phase approval (the company's fifth) in Germany for Vitaros.<br>     </li>     <li>The company says the five remaining European phase approvals should be obtainable in Q4 and Q1 2014.</li>     <li>Vitaros' application for marketing approval is approved under the Decentralized Procedure. The Netherlands is the RMS.</li>     <li>APRI has multiple partners for the ED treatment including Takeda (<a href=\"https://seekingalpha.com/symbol/TKPHF\" title=\"Takeda Pharmaceutical Co., Ltd.\">OTCPK:TKPHF</a>), Sandoz, and Abbott (NYSE:<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a>). (PR)</li>     <li>APRI <font color=\"green\">+10%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316232\" data-linked=\"Apricus Biosciences jumps on German phase approval for Vitaros\" data-tweet=\"$SEEL $SEEL $TKPHF - Apricus Biosciences jumps on German phase approval for Vitaros https://seekingalpha.com/news/1316232-apricus-biosciences-jumps-on-german-phase-approval-for-vitaros?source=tweet\" data-url=\"https://seekingalpha.com/news/1316232-apricus-biosciences-jumps-on-german-phase-approval-for-vitaros\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316212\" data-ts=\"1381148996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGY\" target=\"_blank\">RLGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316212-goldman-makes-a-couple-of-housing-calls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman makes a couple of housing calls</a></h4><ul>\n<li>Goldman likes the brokerage business, upping Realogy (NYSE:<a href=\"https://seekingalpha.com/symbol/RLGY\" title=\"Realogy Holdings\">RLGY</a>) to Buy saying worries about royalty rates and commission splits, broad housing concerns, and large stock sales <a href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Realogy+%28RLGY%29+to+Buy/8754098.html\" target=\"_blank\">are already priced into</a> the stock. \"We expect these issues to diminish over the coming quarters.\"</li>\n<li>How to buy Realogy? Take the cash from a sale of Toll Bros. (NYSE:<a href=\"https://seekingalpha.com/symbol/TOL\" title=\"Toll Brothers Inc.\">TOL</a>), says Goldman, <a href=\"http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Toll+Bros.+%28TOL%29+to+Neutral/8754102.html\" target=\"_blank\">removing its Buy</a> rating on the homebuilder. Despite the downgrade, Goldman still likes Toll's position at the high end of the market and sees room for material margin expansion as the company works through its land-development progress.</li>\n<li>TOL <font color=\"red\">-2.4%</font>, RLGY <font color=\"green\">+0.4%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316212\" data-linked=\"Goldman makes a couple of housing calls\" data-tweet=\"$RLGY $RLGY $TOL - Goldman makes a couple of housing calls https://seekingalpha.com/news/1316212-goldman-makes-a-couple-of-housing-calls?source=tweet\" data-url=\"https://seekingalpha.com/news/1316212-goldman-makes-a-couple-of-housing-calls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316112\" data-ts=\"1381147206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OUTR\" target=\"_blank\">OUTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316112-outerwall-higher-with-jana-in-the-background\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outerwall higher with Jana in the background</a></h4><ul> <li>Shares of Outerwall (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OUTR\" title=\"Outerwall Inc.\">OUTR</a>) reach even greater heights as the <a href=\"https://seekingalpha.com/currents/post/1315302\" target=\"_blank\">news</a> of the significant stake by Jana Partners in the company turns sentiment around.</li> <li>Wedbush <a href=\"http://www.businessweek.com/news/2013-10-07/redbox-owner-gains-after-jana-partners-says-it-will-seek-breakup\" target=\"_blank\">sees</a> Jana gaining enough support from other shareholders to force a significant buyback initiative from Outerwall at the least and thinks it might even convince shareholders to back a breakup.</li>  <li>OUTR <font color=\"green\">+7.8%</font> premarket to $61.59 to mark its highest trading level in over a month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1316112\" data-linked=\"Outerwall higher with Jana in the background\" data-tweet=\"$OUTR - Outerwall higher with Jana in the background https://seekingalpha.com/news/1316112-outerwall-higher-with-jana-in-the-background?source=tweet\" data-url=\"https://seekingalpha.com/news/1316112-outerwall-higher-with-jana-in-the-background\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316092\" data-ts=\"1381146582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316092-facebook-cut-from-strong-buy-at-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook cut from Strong Buy at Raymond James</a></h4><ul>\n<li>RayJay's Aaron Kessler - who banged the drum for Facebook (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a>) with an upgrade to Buy <a href=\"https://seekingalpha.com/currents/post/785221\" target=\"_blank\">in January</a> and an upgrade to Strong Buy <a href=\"https://seekingalpha.com/currents/post/974691\" target=\"_blank\">in April</a> (at prices well south of today's) - cuts his rating <a href=\"http://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+Facebook+%28FB%29+to+Outperform/8754273.html\" target=\"_blank\">back to Buy</a> following the big run in the stock price.</li>\n<li>Kessler says his bullish thesis on the company is playing out as expected, but today's high valuation merits the downgrade.</li>\n<li>Shares <font color=\"red\">off 1.2%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1316092\" data-linked=\"Facebook cut from Strong Buy at Raymond James\" data-tweet=\"$FB - Facebook cut from Strong Buy at Raymond James https://seekingalpha.com/news/1316092-facebook-cut-from-strong-buy-at-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/1316092-facebook-cut-from-strong-buy-at-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1316082\" data-ts=\"1381146541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1316082-cooper-tire-and-rubber-down-sharply-on-buyout-turmoil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cooper Tire &amp; Rubber down sharply on buyout turmoil</a></h4><ul> <li>Shares of Cooper Tire &amp; Rubber (NYSE:<a href=\"https://seekingalpha.com/symbol/CTB\" title=\"Cooper Tire &amp; Rubber Co.\">CTB</a>) dive after Apollo Tires makes a lot of noise about <a href=\"https://seekingalpha.com/currents/post/1315812\" target=\"_blank\">lowering</a> the purchase price of the company below $35.</li> <li>CTB <font color=\"red\">-12.6%</font> premarket to $25.81.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1316082\" data-linked=\"Cooper Tire &amp; Rubber down sharply on buyout turmoil\" data-tweet=\"$CTB - Cooper Tire &amp; Rubber down sharply on buyout turmoil https://seekingalpha.com/news/1316082-cooper-tire-and-rubber-down-sharply-on-buyout-turmoil?source=tweet\" data-url=\"https://seekingalpha.com/news/1316082-cooper-tire-and-rubber-down-sharply-on-buyout-turmoil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1315852\" data-ts=\"1381133665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1315852-continued-impasse-in-washington-hits-equities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Continued impasse in Washington hits equities</a></h4><ul>   <li>Global equities are lower after John Boehner said the GOP <a href=\"https://seekingalpha.com/currents/post/1315772\" target=\"_blank\">won't agree</a> to support legislation to finance the government or raise the debt ceiling until the Democrats agree to talks about reducing the deficit.</li>    <li>\"The U.S. shutdown saga is <a href=\"http://www.bloomberg.com/news/2013-10-07/european-stock-index-futures-retreat-amid-u-s-shutdown.html\" target=\"_blank\">starting to really roil markets</a>,\" says Capital Spreads trader Jonathan Sudaria. \"What was once thought to be a case of chest thumping by politicians may have been underestimated by markets.\"</li>        <li>Japan <font color=\"red\">-1.2%</font>, Hong Kong <font color=\"red\">-0.8%</font>, China closed. India <font color=\"red\">-0.6%</font>.</li>    <li>EU Stoxx 50 <font color=\"red\">-1.1%</font>, London <font color=\"red\">-0.7%</font>, Paris <font color=\"red\">-1.3%</font>, Frankfurt <font color=\"red\">-1.2%</font>, Milan <font color=\"red\">-0.4%</font>, Madrid <font color=\"red\">-0.8%</font>.</li>    <li>U.S. stock futures: Dow <font color=\"red\">-0.9%</font>. S&amp;P <font color=\"red\">-1%</font>. Nasdaq <font color=\"red\">-1%</font>.</li>    <li>Crude <font color=\"red\">-1%</font> to $102.82, Gold <font color=\"green\">+0.05%</font> to $1310.60.</li>    <li>U.S. Dollar index <font color=\"red\">-0.2%</font>.</li>    <li>Ten-year Treasury yield -3 bps to 2.62%.</li>    <li>ETFs: <a href=\"https://seekingalpha.com/symbol/ezu\" title=\"iShares MSCI EMU ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/vgk\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/fez\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/iev\" title=\"iShares Europe ETF\">IEV</a>,  <a href=\"https://seekingalpha.com/symbol/adru\" title=\"BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/fep\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/fdd\" title=\"First Trust Dow Jones STOXX European Select Dividend 30 Index ETF\">FDD</a>, <a href=\"https://seekingalpha.com/symbol/upv\" title=\"ProShares Ultra Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/dfe\" title=\"WisdomTree Europe SmallCap Dividend ETF\">DFE</a>, <a href=\"https://seekingalpha.com/symbol/feu\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/feeu\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>, <a href=\"https://seekingalpha.com/symbol/adra\" title=\"BLDRS Asia 50 ADR Index ETF\">ADRA</a>, <a href=\"https://seekingalpha.com/symbol/aia\" title=\"iShares Asia 50 ETF\">AIA</a>, <a href=\"https://seekingalpha.com/symbol/vpl\" title=\"Vanguard FTSE Pacific ETF\">VPL</a>, <a href=\"https://seekingalpha.com/symbol/asdr\" title=\"VelocityShares Emerging Asia Depositary Receipt ETF\">ASDR</a>, <a href=\"https://seekingalpha.com/symbol/aaxj\" title=\"iShares MSCI All Country Asia ex-Japan Index ETF\">AAXJ</a>, <a href=\"https://seekingalpha.com/symbol/axjs\" title=\"iShares MSCI All Country Asia ex-Japan Small Cap Index ETF\">AXJS</a>, <a href=\"https://seekingalpha.com/symbol/epp\" title=\"iShares MSCI Pacific ex Japan ETF\">EPP</a>, <a href=\"https://seekingalpha.com/symbol/gmf\" title=\"SPDR S&amp;P Emerging Asia Pacific ETF\">GMF</a>, <a href=\"https://seekingalpha.com/symbol/gmfs\" title=\"SPDR S&amp;P Small Cap Emerging Asia Pacific ETF\">GMFS</a>, <a href=\"https://seekingalpha.com/symbol/axjl\" title=\"WisdomTree Asia-Pacific ex-Japan ETF\">AXJL</a>, <a href=\"https://seekingalpha.com/symbol/uxj\" title=\"ProShares Ultra MSCI Pacific Ex-Japan ETF\">UXJ</a>, <a href=\"https://seekingalpha.com/symbol/jpx\" title=\"ProShares UltraShort MSCI Pacific ex-Japan ETF\">JPX</a>, <a href=\"https://seekingalpha.com/symbol/paf\" title=\"PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio ETF\">PAF</a>, <a href=\"https://seekingalpha.com/symbol/asea\" title=\"Global X FTSE ASEAN 40 ETF\">ASEA</a>, <a href=\"https://seekingalpha.com/symbol/eema\" title=\"iShares MSCI Emerging Markets Asia Index ETF\">EEMA</a>, <a href=\"https://seekingalpha.com/symbol/dvya\" title=\"iShares Asia/Pacific Dividend ETF\">DVYA</a>, <a href=\"https://seekingalpha.com/symbol/efa\" title=\"iShares MSCI EAFE ETF\">EFA</a>, <a href=\"https://seekingalpha.com/symbol/iefa\" title=\"iShares Core MSCI EAFE ETF\">IEFA</a>, <a href=\"https://seekingalpha.com/symbol/vea\" title=\"Vanguard FTSE Developed Markets ETF\">VEA</a>, <a href=\"https://seekingalpha.com/symbol/adrd\" title=\"BLDRS Developed Markets 100 ADR Index ETF\">ADRD</a>, <a href=\"https://seekingalpha.com/symbol/mfla\" title=\"iPath Long Enhanced 2x MSCI EAFE Index ETN\">MFLA</a>, <a href=\"https://seekingalpha.com/symbol/efo\" title=\"ProShares Ultra MSCI EAFE ETF\">EFO</a>, <a href=\"https://seekingalpha.com/symbol/efu\" title=\"ProShares UltraShort MSCI EAFE ETF\">EFU</a>, <a href=\"https://seekingalpha.com/symbol/pdn\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio ETF\">PDN</a>, <a href=\"https://seekingalpha.com/symbol/piz\" title=\"PowerShares DWA Developed Markets Momentum Portfolio ETF\">PIZ</a>, <a href=\"https://seekingalpha.com/symbol/efz\" title=\"ProShares Short MSCI EAFE ETF\">EFZ</a>, <a href=\"https://seekingalpha.com/symbol/pxf\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Portfolio ETF\">PXF</a>, <a href=\"https://seekingalpha.com/symbol/efg\" title=\"iShares MSCI EAFE Growth ETF\">EFG</a>, <a href=\"https://seekingalpha.com/symbol/efv\" title=\"iShares MSCI EAFE Value ETF\">EFV</a>, <a href=\"https://seekingalpha.com/symbol/dzk\" title=\"Direxion Developed Markets Bull 3X Shares ETF\">DZK</a>, <a href=\"https://seekingalpha.com/symbol/dpk\" title=\"Direxion Developed Markets Bear 3X Shares ETF\">DPK</a>, <a href=\"https://seekingalpha.com/symbol/idlv\" title=\"PowerShares S&amp;P International Developed Low Volatility Portfolio ETF\">IDLV</a>, <a href=\"https://seekingalpha.com/symbol/dth\" title=\"WisdomTree DEFA  Equity Income ETF\">DTH</a>, <a href=\"https://seekingalpha.com/symbol/dwm\" title=\"WisdomTree DEFA  ETF\">DWM</a>, <a href=\"https://seekingalpha.com/symbol/urth\" title=\"iShares MSCI World ETF\">URTH</a>, <a href=\"https://seekingalpha.com/symbol/fdts\" title=\"First Trust Developed Markets ex-US Small Cap AlphaDEX ETF\">FDTS</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1315852\" data-linked=\"Continued impasse in Washington hits equities\" data-tweet=\"$EZU $VGK $FEZ - Continued impasse in Washington hits equities https://seekingalpha.com/news/1315852-continued-impasse-in-washington-hits-equities?source=tweet\" data-url=\"https://seekingalpha.com/news/1315852-continued-impasse-in-washington-hits-equities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 AM </div></div></li>","count":40,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}